PHIO PHARMACEUTICALS CORP's ticker is PHIOW and the CUSIP is 71880W105. A total of 3 filers reported holding PHIO PHARMACEUTICALS CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,000 | +33.3% | 24,591 | +40.0% | 0.00% | – |
| Q2 2020 | $3,000 | +200.0% | 17,569 | -65.5% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 50,888 | +1.1% | 0.00% | – |
| Q3 2019 | $1,000 | -83.3% | 50,323 | -66.6% | 0.00% | – |
| Q2 2019 | $6,000 | – | 150,669 | +767.8% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 17,363 | -46.8% | 0.00% | – |
| Q4 2018 | $1,000 | – | 32,663 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 86,299 | $232,000 | 0.05% |
| UBS Group AG | 899 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 3,000 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |